273 related articles for article (PubMed ID: 16417670)
1. Visual side-effects from transdermal scopolamine (hyoscine).
Firth AY; Walker K
Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
[TBL] [Abstract][Full Text] [Related]
2. Hyoscine skin patches for drooling dilate pupils and impair accommodation: spectacle correction for photophobia and blurred vision may be warranted.
Saeed M; Henderson G; Dutton GN
Dev Med Child Neurol; 2007 Jun; 49(6):426-8. PubMed ID: 17518927
[TBL] [Abstract][Full Text] [Related]
3. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
4. Control of drooling using transdermal scopolamine skin patches. A case report.
Mato Montero A; Limeres Posse J; Tomás Carmona I; Fernández Feijoo J; Diz Dios P
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E27-30. PubMed ID: 18167476
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermia associated with central anticholinergic syndrome caused by a transdermal hyoscine patch in a child with cerebral palsy.
Frampton A; Spinks J
Emerg Med J; 2005 Sep; 22(9):678-9. PubMed ID: 16113205
[No Abstract] [Full Text] [Related]
6. Esotropia in a child treated with a scopolamine patch for drooling.
Good WV; Crain LS
Pediatrics; 1996 Jan; 97(1):126-7. PubMed ID: 8545207
[No Abstract] [Full Text] [Related]
7. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
[TBL] [Abstract][Full Text] [Related]
8. Scopolamine: new preparations. Reference treatment for death rattle.
Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188
[TBL] [Abstract][Full Text] [Related]
9. Transdermal scopolamine use for post-rhytidectomy sialocele.
Lapid O; Kreiger Y; Sagi A
Aesthetic Plast Surg; 2004; 28(1):24-8. PubMed ID: 15116278
[TBL] [Abstract][Full Text] [Related]
10. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
Trials; 2014 Feb; 15():60. PubMed ID: 24533890
[TBL] [Abstract][Full Text] [Related]
11. Control of drooling with transdermal scopolamine in a child with cerebral palsy.
Siegel LK; Klingbeil MA
Dev Med Child Neurol; 1991 Nov; 33(11):1013-4. PubMed ID: 1743423
[TBL] [Abstract][Full Text] [Related]
12. Scopolamine bioavailability in combined oral and transdermal delivery.
Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
[TBL] [Abstract][Full Text] [Related]
13. Transdermal scopolamine for reduction of drooling in developmentally delayed children.
Lewis DW; Fontana C; Mehallick LK; Everett Y
Dev Med Child Neurol; 1994 Jun; 36(6):484-6. PubMed ID: 7516297
[TBL] [Abstract][Full Text] [Related]
14. Transdermal scopolamine: human performance and side effects.
Gordon C; Binah O; Attias J; Rolnick A
Aviat Space Environ Med; 1986 Mar; 57(3):236-40. PubMed ID: 3964152
[TBL] [Abstract][Full Text] [Related]
15. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
[TBL] [Abstract][Full Text] [Related]
16. Treatment of drooling with scopolamine in pediatric ICU: A case series report.
Franco JB; Cacita N; Freua KA; Ortega KL; de Melo Peres MPS
Spec Care Dentist; 2018 Nov; 38(6):362-366. PubMed ID: 30238487
[TBL] [Abstract][Full Text] [Related]
17. Transdermal scopolamine in drooling.
Brodtkorb E; Wyzocka-Bakowska MM; Lillevold PE; Sandvik L; Saunte C; Hestnes A
J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():233-7. PubMed ID: 3047394
[TBL] [Abstract][Full Text] [Related]
18. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
[TBL] [Abstract][Full Text] [Related]
19. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.
Parrott AC
Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072
[TBL] [Abstract][Full Text] [Related]
20. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
Shupak A; Gordon CR; Spitzer O; Mendelowitz N; Melamed Y
Pharmatherapeutica; 1989; 5(6):365-70. PubMed ID: 2594820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
